Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 717.26B | 811.27B | 706.66B | 708.69B | 716.41B | 733.85B |
Gross Profit | 218.57B | 247.19B | 214.51B | 212.46B | 216.27B | 222.04B |
EBITDA | 8.26B | 24.54B | 18.55B | 20.79B | 25.94B | 32.11B |
Net Income | -2.22B | 810.00M | 1.01B | 1.34B | 5.37B | 8.85B |
Balance Sheet | ||||||
Total Assets | 388.85B | 382.60B | 285.50B | 278.73B | 280.74B | 285.09B |
Cash, Cash Equivalents and Short-Term Investments | 24.93B | 35.74B | 21.14B | 25.63B | 32.50B | 38.12B |
Total Debt | 56.79B | 63.13B | 44.42B | 42.77B | 39.83B | 35.00B |
Total Liabilities | 188.78B | 179.27B | 135.26B | 128.71B | 128.50B | 136.29B |
Stockholders Equity | 200.08B | 203.33B | 150.25B | 150.02B | 151.68B | 148.34B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -8.19B | -2.37B | -5.32B | -8.47B | 12.91B |
Operating Cash Flow | 0.00 | 14.48B | 21.50B | 15.21B | 16.02B | 29.92B |
Investing Cash Flow | 0.00 | -16.26B | -25.55B | -22.80B | -24.32B | -15.94B |
Financing Cash Flow | 0.00 | 6.94B | -442.00M | 495.00M | 2.39B | 4.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥140.27B | 10.14 | 2.99% | 5.77% | 15.54% | ||
62 Neutral | ¥178.19B | 175.32 | 1.76% | 23.04% | ― | ||
62 Neutral | C$5.19B | 9.07 | 20.23% | 3.58% | 3.46% | 8.83% | |
$1.26B | 16.17 | 7.98% | 2.71% | ― | ― | ||
65 Neutral | ¥123.35B | 37.96 | 1.80% | 7.54% | -47.00% | ||
65 Neutral | ¥221.72B | 18.41 | 2.90% | 18.53% | -36.19% | ||
58 Neutral | ¥174.67B | 35.90 | 1.49% | 1.54% | -15.67% |